BLLXF - Sire Bioscience Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2019-09-30
2019-03-31
2018-03-31
2017-03-31
Total Revenue
-62.5
0
125
50
0.116
Operating Expenses
Research Development
-
-
52.259
85.999
0.985
Selling General and Administrative
1,409
1,563
1,828
284.974
142.025
Total Operating Expenses
1,398
1,563
1,881
370.973
143.01
Operating Income or Loss
-1,460
-1,563
-1,756
-320.973
-142.894
Interest Expense
-
679.297
-
-
-
Total Other Income/Expenses Net
-
-4,157
-131.1
41.876
-
Income Before Tax
-6,455
-6,396
-1,884
-276.213
-141.72
Income from Continuing Operations
-6,455
-6,396
-1,884
-276.213
-141.72
Net Income
-6,455
-6,396
-1,884
-276.213
-141.72
Net Income available to common shareholders
-6,455
-6,396
-1,884
-276.213
-141.72
Basic EPS
-
-0.04
-0.02
-0.01
-0.01
Diluted EPS
-
-0.04
-0.02
-0.01
-0.01
Basic Average Shares
-
144,336
108,265
44,408
30,345
Diluted Average Shares
-
144,336
108,265
44,408
30,345
EBITDA
-
-5,717
-1,756
-320.973
-142.894